Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL937102

CC(N)=O.O=C(O)C(F)(F)F

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.53
ALOX15 P16050 1/20 0.53
BLM P54132 1/20 0.53
PMP22 Q01453 1/20 0.53
ACHE P22303 1/20 0.38
FFAR3 O14843 1/20 0.38
LCK P06239 1/20 0.38
FYN P06241 1/20 0.38
NOS1 P29475 2/20 0.37
NOS2 P35228 2/20 0.37
ALDH1A1 P00352 4/20 0.37
TSHR P16473 2/20 0.37
TDP1 Q9NUW8 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LDHA P00338 1/20 0.33
LDHB P07195 1/20 0.33
THRB P10828 1/20 0.33
F2 P00734 1/20 0.33
F11 P03951 1/20 0.33
PRSS1 P07477 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL22557988 1.00 LMNA (0.53) LMNAALOX15BLMPMP22ACHE
Trifluoroacetic Acid SCHEMBL29921600 1.00 LMNA (0.53) LMNAALOX15BLMPMP22ACHE
Trifluoroacetic Acid SCHEMBL5744812 1.00 LMNA (0.53) LMNAALOX15BLMPMP22ACHE
Trifluoroacetic Acid SCHEMBL6542389 0.88 LMNA (0.39) LMNAALOX15BLMPMP22ACHE
Trifluoroacetic Acid SCHEMBL3945276 0.87 FFAR3 (0.47) LMNAALOX15BLMPMP22FFAR3
Trifluoroacetic Acid SCHEMBL5747984 0.86 ALDH1A1 (0.46) LMNAALOX15BLMPMP22ACHE
Trifluoroacetic Acid SCHEMBL3906649 0.86 ALDH1A1 (0.46) LMNAALOX15BLMPMP22ACHE
Trifluoroacetic Acid SCHEMBL934980 0.86 ACHE (0.54) LMNAALOX15BLMPMP22ACHE
Trifluoroacetic Acid SCHEMBL15533970 0.86 ACHE (0.54) LMNAALOX15BLMPMP22ACHE
Trifluoroacetic Acid SCHEMBL479935 0.86 FFAR3 (0.54) LMNAALOX15BLMPMP22FFAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 284 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108026094-A Substituted 4-azaindoles and their use as modulators of the G L UN2B receptor 詹森药业有限公司 2018-05-11 CN claimed
CN-104271552-B Substituted heterocyclic acetamides as KAPPA Opioid Receptor (KOR) agonists 雷迪博士实验室有限公司 2017-08-08 CN claimed
CN-103189373-A Substituted triazolopyridines BAYER IP GMBH 2013-07-03 CN claimed
WO-2010147234-A1 DIARYLAMIDE-SPIRODIAMINE DERIVATIVE BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-12-23 WO claimed
CN-1759118-B Diazepinoindole derivatives as kinase inhibitors PFIZER 2010-12-08 CN claimed
EP-2249646-A1 DUAL PHARMACOPHORES - PDE4-MUSCARINIC ANTAGONISTICS Glaxo Group Limited (GB) 2010-11-17 EP claimed
CN-101107249-B purine derivatives as A2A receptor agonists NOVARTIS AG 2010-10-13 CN claimed
CN-101511429-A Indulines derivatives and gpr119 agonists SMITHKLINE BEECHAM CORP (US) 2009-08-19 CN claimed
WO-2009100169-A1 DUAL PHARMACOPHORES - PDE4-MUSCARINIC ANTAGONISTICS GLAXO GROUP LIMITED (GB) 2009-08-13 WO claimed
CN-101360716-A Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer s disease, neurodegeneration and dementia ASTRAZENECA AB (SE) 2009-02-04 CN claimed
EP-1699791-A1 NOVEL TRICYCLIC SPIRODERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY AstraZeneca AB (SE) 2006-09-13 EP claimed
CN-1759118-A Diazepinoindole derivatives as kinase inhibitors PFIZER (US) 2006-04-12 CN claimed
CN-1229343-C Novel compounds ASTRAZENECA AB (SE) 2005-11-30 CN claimed
WO-2005105814-A1 TETRACYCLIC INHIBITORS OF JANUS KINASES INCYTE CORPORATION (US) 2005-11-10 WO claimed
CN-1675218-A Novel tricyclic spiropiperidines or spiropyrrolidines ASTRAZENECA AB (SE) 2005-09-28 CN claimed
WO-2005061499-A1 NOVEL TRICYCLIC SPIRODERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY ASTRAZENECA AB (SE) 2005-07-07 WO claimed
WO-2005048916-A2 TETRAHYDROSPIRO-BETA-CARBOLINE-1,3 '-PYRROLIDINE DERIVATIVES AND THEIR USE IN GHSR-RELATED DISORDERS BIOVITRUM AB (SE) 2005-06-02 WO claimed
CN-1509281-A Benzimidazol derivatives modulate che mokine receptors 2004-06-30 CN claimed
CN-1426393-A Novel compounds ASTRAZENECA AB (SE) 2003-06-25 CN claimed
CN-1190395-A Substituted (sulfonic, sulfinic, sulfonamido or sulfonamido) N- [ aminoiminomethyl) phenylalkyl ] -azaheterocyclic amide compounds RHONE POULENC RORER PHARMA (US) 1998-08-12 CN claimed